Published in World J Gastroenterol on November 07, 2008
Intrahepatic cholangiocarcinoma. Surg Oncol Clin N Am (2014) 0.95
A single-center analysis of the survival benefits of adjuvant gemcitabine chemotherapy for biliary tract cancer. Int J Clin Oncol (2013) 0.88
Adjuvant treatment in biliary tract cancer: to treat or not to treat? World J Gastroenterol (2012) 0.83
Cholangiocarcinoma: has there been any progress? Can J Gastroenterol (2010) 0.82
Synchronous double primary cancer - intrahepatic cholangiocarcinoma with bone metastases and thyroid carcinoma: A case report. Oncol Lett (2015) 0.79
Predictors and patterns of recurrence after curative liver resection in intrahepatic cholangiocarcinoma, for application of postoperative radiotherapy: a retrospective study. World J Surg Oncol (2015) 0.75
Decision Making: Intra-arterial Therapies for Cholangiocarcinoma-TACE and TARE. Semin Intervent Radiol (2017) 0.75
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med (2003) 9.09
Cholangiocarcinoma. Lancet (2005) 6.01
The epidemiology of cholangiocarcinoma. Semin Liver Dis (2004) 5.59
Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg (1996) 5.42
Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology (2001) 5.12
Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol (2004) 4.39
Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg (2007) 3.73
Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut (2001) 3.45
Cholangiocarcinoma. Gastroenterology (2005) 3.15
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol (2007) 2.90
Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol (2002) 2.70
Worldwide trends in mortality from biliary tract malignancies. BMC Cancer (2002) 2.61
Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg (2001) 2.57
Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. J Clin Oncol (2005) 2.51
Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl (2000) 2.23
A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol (2004) 2.23
Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology (1998) 2.19
Pathological aspects of cholangiocarcinoma. J Pathol (1983) 1.87
Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea. Int J Epidemiol (1996) 1.86
Aggressive surgical resection for cholangiocarcinoma. Arch Surg (1995) 1.80
Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation (2000) 1.79
Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg (2004) 1.77
Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg (1998) 1.72
Clinicopathologic studies on perineural invasion of bile duct carcinoma. Ann Surg (1992) 1.69
A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures. Clin Gastroenterol Hepatol (2004) 1.66
A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: histologic classification and modes of spreading. Hum Pathol (1988) 1.56
Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology. J Gastroenterol Hepatol (2002) 1.52
Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Sci (2004) 1.48
Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality. Langenbecks Arch Surg (2003) 1.48
Surgical treatment of cholangiocellular carcinoma. World J Surg (1995) 1.47
Racial and ethnic variations in the epidemiology of intrahepatic cholangiocarcinoma in the United States. Liver Int (2006) 1.45
A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer (2001) 1.40
Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg (1997) 1.36
Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg (2004) 1.35
Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period. Ann Surg (2005) 1.32
Resection of intrahepatic cholangiocarcinoma: a Western experience. J Hepatobiliary Pancreat Surg (1999) 1.31
Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery (2000) 1.25
Surgical management of intrahepatic cholangiocarcinoma: a 31-year experience. J Hepatobiliary Pancreat Surg (1998) 1.24
Surgical treatment of intrahepatic cholangiocarcinoma: four patients surviving more than five years. Surgery (1992) 1.23
Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg (2001) 1.20
Magnetic resonance imaging of cholangiocarcinoma. Semin Liver Dis (2004) 1.20
Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma. World J Surg (2005) 1.18
Clinicopathological features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg (1999) 1.17
Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings. Am J Gastroenterol (2000) 1.15
Cholangiocarcinoma: emerging approaches to a challenging cancer. Curr Opin Gastroenterol (2007) 1.14
Optical coherence tomography of the biliary tree during ERCP. Gastrointest Endosc (2002) 1.14
What is the current state-of-the-art imaging for detection and staging of cholangiocarcinoma? Oncologist (2006) 1.14
Intrahepatic cholangiocarcinoma. World J Surg (1997) 1.11
EUS-guided fine-needle aspiration cytodiagnosis of hilar cholangiocarcinoma: a case series. Gastrointest Endosc (2000) 1.11
Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes. J Am Coll Surg (1998) 1.11
Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging (2003) 1.10
Hepatic resection of the intraductal papillary type of peripheral cholangiocarcinoma. Ann Surg Oncol (2004) 1.09
Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures. Gut (2000) 1.08
Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002. J Natl Cancer Inst (2007) 1.07
Combination chemotherapy with gemcitabine and cisplatin as first-line treatment for immunohistochemically proven cholangiocarcinoma. Am J Clin Oncol (2006) 1.07
Clinicopathological factors predicting outcome after resection of mass-forming intrahepatic cholangiocarcinoma. Br J Surg (2001) 1.06
Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma. Am J Surg (2002) 1.05
Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma. World J Surg (2007) 1.05
Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI. J Comput Assist Tomogr (1999) 1.03
Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment. Br J Surg (1998) 1.03
Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities. Surgery (2002) 1.03
A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma. Cancer (1998) 1.00
Endoscopic management of cholangiocarcinoma. Semin Liver Dis (2004) 0.99
Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18-year period. J Gastrointest Surg (2007) 0.99
Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg (2005) 0.99
Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy. Ann Surg (2006) 0.99
Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience. Liver Transpl (2005) 0.98
Fine-needle aspiration biopsy of hepatic lesions: computerized tomographic-guided versus endoscopic ultrasound-guided FNA. Cancer (2006) 0.98
Lymph node metastasis in intrahepatic cholangiocarcinoma. Jpn J Clin Oncol (1999) 0.98
The significance of stromal desmoplasia in intrahepatic cholangiocarcinoma: a special reference of 'scirrhous-type' and 'nonscirrhous-type' growth. Am J Surg Pathol (1999) 0.98
Recurrence after surgical resection of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg (2001) 0.97
Prognostic factors of resectable intrahepatic cholangiocarcinoma. J Surg Oncol (1995) 0.96
Predictive factors for long-term survival in patients with intrahepatic cholangiocarcinoma. Am J Surg (2001) 0.96
Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type. Am J Surg Pathol (2007) 0.95
Role of laparoscopy in the evaluation of biliary tract cancer. Surg Oncol Clin N Am (2002) 0.95
Lymphatic spreading pattern of intrahepatic cholangiocarcinoma. Surgery (2001) 0.95
Increasing incidence of cholangiocarcinoma in Crete 1992-2000. Anticancer Res (2003) 0.95
MR imaging of intrahepatic cholangiocarcinoma: use of ferumoxides for lesion localization and extension. AJR Am J Roentgenol (2001) 0.92
Extended hepatic resection and outcomes in intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg (2003) 0.90
Review of endoscopic ultrasound-guided fine-needle aspiration cytology. Diagn Cytopathol (2006) 0.90
Patterns of regional lymph node involvement in intrahepatic cholangiocarcinoma of the left lobe. J Gastrointest Surg (2003) 0.90
Extended resection for intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg (1999) 0.90
Long-term survival after extended surgical resection of intrahepatic cholangiocarcinoma with extensive lymph node metastasis. Hepatogastroenterology (2005) 0.88
Descriptive epidemiology of subsites of cancers of the liver, biliary tract and pancreas in Japan. Jpn J Clin Oncol (1990) 0.86
Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer. Jpn J Clin Oncol (2006) 0.85
Irinotecan with 5-FU/FA in advanced biliary tract adenocarcinomas: a multicenter phase II trial. Am J Clin Oncol (2007) 0.85
Successful duct-to-duct biliary reconstruction after right hemihepatectomy. Operative planning using virtual 3D reconstructed images. J Gastrointest Surg (2007) 0.84
Clinicopathologic features, diagnosis and surgical treatment of intrahepatic cholangiocarcinoma in 104 patients. Hepatobiliary Pancreat Dis Int (2004) 0.84
Intrahepatic cholangiocarcinoma in Korea. J Hepatobiliary Pancreat Surg (1999) 0.82
Chemotherapy for hepatocellular carcinoma with portal hypertension due to tumor thrombus. J Clin Gastroenterol (2000) 0.81
A long-term survivor of intrahepatic cholangiocarcinoma with lymph node metastasis: a case report. Jpn J Clin Oncol (2002) 0.81
Radiofrequency ablation of recurrent cholangiocarcinoma after orthotopic liver transplantation -- a case report. World J Gastroenterol (2005) 0.81
Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma. Hepatogastroenterology (2007) 0.80
MR imaging patterns of gadolinium retention within liver neoplasms. Abdom Imaging (1999) 0.80
Do increases in mortality from intrahepatic cholangiocarcinoma reflect a genuine increase in risk? Insights from cancer registry data in Scotland. Eur J Cancer (2003) 0.79
Extended right hepatic lobectomy with resection of inferior vena cava and portal vein for intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg (2000) 0.79
Long-term survival of peripheral intrahepatic cholangiocarcinoma with metastasis to the para-aortic lymph nodes. Surgery (2000) 0.78
[Malignant biliary hilar stenosis: MR cholangiography compared with direct cholangiography]. Radiol Med (2001) 0.78
Clinical characteristics and proliferating activity of intrahepatic cholangiocarcinoma. J Gastroenterol Hepatol (1995) 0.77
Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma. Hepatobiliary Pancreat Dis Int (2007) 1.56
Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int (2015) 1.39
Health-related quality of life of 256 recipients after liver transplantation. World J Gastroenterol (2012) 1.07
Is absolute lymphocyte count a good prognostic predictor in recurrence of hepatocellular carcinoma after liver transplantation? Transplantation (2014) 1.07
Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma. World J Gastroenterol (2013) 1.02
Up-regulation of IRAK-M is essential for endotoxin tolerance induced by a low dose of lipopolysaccharide in Kupffer cells. J Surg Res (2008) 0.99
Analysis of infections in the first 3-month after living donor liver transplantation. World J Gastroenterol (2012) 0.99
Clinical study on safety of adult-to-adult living donor liver transplantation in both donors and recipients. World J Gastroenterol (2007) 0.94
Hepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinoma. Cancer Lett (2008) 0.93
Relevant markers of cancer stem cells indicate a poor prognosis in hepatocellular carcinoma patients: a meta-analysis. Eur J Gastroenterol Hepatol (2013) 0.92
Outcome of hepatocellular carcinoma treated by liver transplantation: comparison of living donor and deceased donor transplantation. Hepatobiliary Pancreat Dis Int (2010) 0.91
Unsuccessful treatment of four patients with acute graft-vs-host disease after liver transplantation. World J Gastroenterol (2012) 0.89
Oxidative DNA damage in peripheral leukocytes and its association with expression and polymorphisms of hOGG1: a study of adolescents in a high risk region for hepatocellular carcinoma in China. World J Gastroenterol (2003) 0.88
Indicators of prognosis after liver transplantation in Chinese hepatocellular carcinoma patients. World J Gastroenterol (2009) 0.88
Improved two-cuff technique for orthotopic liver transplantation in rat. Hepatobiliary Pancreat Dis Int (2004) 0.87
Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation. Hepatobiliary Pancreat Dis Int (2004) 0.87
Hemihepatic versus total hepatic inflow occlusion during hepatectomy: a systematic review and meta-analysis. World J Gastroenterol (2011) 0.86
Prolongation of liver allograft survival by dendritic cells modified with NF-kappaB decoy oligodeoxynucleotides. World J Gastroenterol (2004) 0.86
Orthotopic liver transplantation for patients with Caroli's disease. Hepatobiliary Pancreat Dis Int (2008) 0.86
Staging of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int (2003) 0.85
Risk factors for in-hospital mortality of patients with high model for end-stage liver disease scores following living donor liver transplantation. Ann Hepatol (2012) 0.84
Preoperative predictors of portal vein thrombosis after splenectomy with periesophagogastric devascularization. World J Gastroenterol (2012) 0.84
Predictors of patient survival following living donor liver transplantation. Hepatobiliary Pancreat Dis Int (2011) 0.84
Incidence and treatment of hepatic artery complications after orthotopic liver transplantation. World J Gastroenterol (2003) 0.84
Evaluation of standard liver volume formulae for Chinese adults. World J Gastroenterol (2009) 0.83
Caudate lobectomy by the third porta hepatis anatomical method: a study of 16 cases. Hepatobiliary Pancreat Dis Int (2006) 0.83
Predictive factors of recurrence for patients with intrahepatic cholangiocarcinoma after hepatectomy. Hepatogastroenterology (2012) 0.83
Analysis of CD8+CD28- T-suppressor cells in living donor liver transplant recipients. Hepatobiliary Pancreat Dis Int (2009) 0.83
Graft size alone should not affect donors selection and be used to predict the prognosis of recipients after living donor liver transplantation. Hepatogastroenterology (2012) 0.82
Effect of apolipoprotein E gene Hha I restricting fragment length polymorphism on serum lipids in cholecystolithiasis. World J Gastroenterol (1999) 0.82
Liver transplantation for patients with hepatolithiasis. Hepatobiliary Pancreat Dis Int (2005) 0.82
Randomized comparison of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of patients with intra-abdominal infection. Asian J Surg (2004) 0.82
Protective effect of nitric oxide induced by ischemic preconditioning on reperfusion injury of rat liver graft. World J Gastroenterol (2004) 0.82
A successful pregnancy following liver transplantation. Hepatobiliary Pancreat Dis Int (2007) 0.82
Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells. Hepatobiliary Pancreat Dis Int (2006) 0.81
Safety of living donor liver transplantation using older donors. J Surg Res (2012) 0.81
Delayed internal pancreatic fistula with pancreatic pleural effusion postsplenectomy. World J Gastroenterol (2010) 0.81
Treatment of hepatic venous outflow stenosis after living donor liver transplantation by insertion of an expandable metallic stent. Hepatobiliary Pancreat Dis Int (2009) 0.81
Evaluation of oxidative stress in a group of adolescents exposed to a high level of aflatoxin B1--a multi-center and multi-biomarker study. Carcinogenesis (2007) 0.81
Microsurgical reconstruction of hepatic artery in A-A LDLT: 124 consecutive cases without HAT. World J Gastroenterol (2010) 0.81
Zinc finger protein A20 protects rats against chronic liver allograft dysfunction. World J Gastroenterol (2012) 0.80
Is correction for protein concentration appropriate for protein adduct dosimetry? Hypothesis and clues from an aflatoxin B1-exposed population. Cancer Sci (2007) 0.80
Risks faced by donors of right lobe for living donor liver transplantation. Hepatobiliary Pancreat Dis Int (2009) 0.80
Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation. World J Gastroenterol (2010) 0.80
Role of cystic fluid in diagnosis of the pancreatic cystadenoma and cystadenocarcinoma. Hepatogastroenterology (2008) 0.80
Measures for increasing the safety of donors in living donor liver transplantation using right lobe grafts. Hepatobiliary Pancreat Dis Int (2007) 0.80
Dynamic alteration of HBV markers on active HBV replicative recipients after liver transplantation: a preliminary report. Hepatobiliary Pancreat Dis Int (2003) 0.80
Hepatic venous outflow reconstruction in right lobe graft without middle hepatic vein. Hepatol Res (2007) 0.80
Problems in adult living donor liver transplantation using the right hepatic lobe. Hepatobiliary Pancreat Dis Int (2006) 0.79
Transplantation vs resection for hepatocellular carcinoma with compensated liver function after downstaging therapy. World J Gastroenterol (2013) 0.79
Cavoportal hemitransposition in liver transplantation: a new technique. Hepatobiliary Pancreat Dis Int (2003) 0.79
Retrospective analysis of prognostic factors after liver transplantation for intrahepatic cholangiocarcinoma in China: a single-center experience. Hepatogastroenterology (2011) 0.79
Evaluation outcomes of donors in living donor liver transplantation: a single-center analysis of 132 donors. Hepatobiliary Pancreat Dis Int (2011) 0.79
Zinc finger protein A20 promotes regeneration of small-for-size liver allograft and suppresses rejection and results in a longer survival in recipient rats. J Surg Res (2008) 0.79
Improved early diagnosis of cystadenocarcinoma of the pancreas. Hepatobiliary Pancreat Dis Int (2007) 0.79
Donor safety and remnant liver volume in living donor liver transplantation. World J Gastroenterol (2012) 0.79
Overexpression of TIMP-1 mediated by recombinant adenovirus in hepatocellular carcinoma cells inhibits proliferation and invasion in vitro. Hepatobiliary Pancreat Dis Int (2006) 0.79
Factors associated with early mortality after living-donor liver transplant. Exp Clin Transplant (2014) 0.78
Combined hepatectomy and radiofrequency ablation versus TACE in improving survival of patients with unresectable BCLC stage B HCC. Hepatobiliary Pancreat Dis Int (2016) 0.78
Posttraumatic stress disorder after liver transplantation. Hepatobiliary Pancreat Dis Int (2012) 0.78
Nuclear factor-kappaB decoy oligodeoxynucleotides attenuates ischemia/reperfusion injury in rat liver graft. World J Gastroenterol (2005) 0.78
Prophylaxis of chronic kidney disease after liver transplantation--experience from west China. World J Gastroenterol (2012) 0.78
Scoring selection criteria including total tumour volume and pretransplant percentage of lymphocytes to predict recurrence of hepatocellular carcinoma after liver transplantation. PLoS One (2013) 0.78
Effects of epidermal growth factor receptor inhibitor genistein on proliferative cholangitis in rats. J Surg Res (2009) 0.78
Augmented regeneration of partial liver allograft induced by nuclear factor-kappaB decoy oligodeoxynucleotides-modified dendritic cells. World J Gastroenterol (2004) 0.78
Quality of life and psychological outcome of donors after living donor liver transplantation. World J Gastroenterol (2012) 0.78
Child-Pugh A hepatitis B-related cirrhotic patients with a single hepatocellular carcinoma up to 5 cm: liver transplantation vs. resection. J Gastrointest Surg (2014) 0.78
Causes of mortality after liver transplantation: a single center experience in mainland china. Hepatogastroenterology (2012) 0.78
Current prophylactic strategies against hepatitis B virus recurrence after liver transplantation. World J Gastroenterol (2009) 0.78
Effect of peroxisome proliferator-activated receptor-gamma ligand on inflammation of human gallbladder epithelial cells. World J Gastroenterol (2005) 0.78
Retrospective study of steroid therapy for patients with autoimmune pancreatitis in a Chinese population. World J Gastroenterol (2013) 0.78
Surgical vs percutaneous radiofrequency ablation for hepatocellular carcinoma in dangerous locations. World J Gastroenterol (2011) 0.78
Up-to-seven criteria for hepatocellular carcinoma liver transplantation: a single center analysis. World J Gastroenterol (2013) 0.78
The pre-Kasai procedure in living donor liver transplantation for children with biliary atresia. Hepatobiliary Pancreat Dis Int (2013) 0.77
Changed clinical aspects of primary liver cancer in China during the past 30 years. Hepatobiliary Pancreat Dis Int (2004) 0.77
Facing up to the threat in China. Lancet (2010) 0.77
Risk factors of SFSS in adult-to-adult living donor liver transplantation using the right liver: a single-center analysis of 217 cases. Hepatogastroenterology (2012) 0.77
Adult-to-adult living donor liver transplantation for malignant metastatic melanoma to the liver. Hepatobiliary Pancreat Dis Int (2010) 0.77
Is hepatectomy for huge hepatocellular carcinoma (≥ 10 cm in diameter) safe and effective? A single-center experience. Asian Pac J Cancer Prev (2014) 0.77
Recent advances in liver-directed gene transfer vectors. Hepatobiliary Pancreat Dis Int (2004) 0.77
Intramuscular hepatitis B immune globulin combined with lamivudine in prevention of hepatitis B recurrence after liver transplantation. Hepatobiliary Pancreat Dis Int (2006) 0.77
Development of a survival evaluation model for liver transplant recipients with hepatocellular carcinoma secondary to hepatitis B. World J Gastroenterol (2008) 0.76
Microproteinuria for detecting calcineurin inhibitor-related nephrotoxicity after liver transplantation. World J Gastroenterol (2009) 0.76
[Diagnosis and treatment of intrahepatic biliary cystadenocarcinoma-a report of 11 cases]. Ai Zheng (2007) 0.76
Management of venous stenosis in living donor liver transplant recipients. World J Gastroenterol (2009) 0.76
Postoperative complications after liver transplantation with cavoportal hemitransposition. Hepatobiliary Pancreat Dis Int (2008) 0.76
[Correlation of somatostatin receptor expression in human hepatocellular carcinoma tissue to serum alpha-fetoprotein concentration]. Ai Zheng (2007) 0.76
"Metroticket" predictor for assessing liver transplantation to treat hepatocellular carcinoma: a single-center analysis in mainland China. World J Gastroenterol (2013) 0.76
Subcellular daunorubicin distribution and its relation to multidrug resistance phenotype in drug-resistant cell line SMMC-7721/R. World J Gastroenterol (2002) 0.76
Hepatic adenylate energy charge levels in patients with hepatoma after hepatic artery embolization. World J Gastroenterol (1998) 0.75
Donor safety in adult living donor liver transplantation using the right lobe: single center experience in China. World J Gastroenterol (2007) 0.75
Autologous transfusion with modified total hepatic vascular exclusion for extracapsular resection of giant hepatic cavernous hemangioma. Hepatobiliary Pancreat Dis Int (2007) 0.75
A rare case of periampullary carcinoma with ectopic ending of Vater's ampulla. World J Gastroenterol (2009) 0.75
Pregnancy after liver transplantation: four-year follow-up of the first case in mainland China. World J Gastroenterol (2008) 0.75
Efficacy of middle hepatic vein reconstruction in adult right-lobe living donor liver transplantation. Hepatobiliary Pancreat Dis Int (2010) 0.75
Potential etiopathogenesis of seventh day syndrome following living donor liver transplantation: ischemia of the graft? Hepatobiliary Pancreat Dis Int (2010) 0.75
Health-related quality of life in living liver donors after transplantation. Hepatobiliary Pancreat Dis Int (2011) 0.75
Comparison of hepatitis B prophylactic outcomes in living donor liver transplantation recipients who meet the Milan or UCSF criteria. Hepatobiliary Pancreat Dis Int (2013) 0.75
Cholangiocarcinoma accompanied by desmoid-type fibromatosis. Hepatobiliary Pancreat Dis Int (2011) 0.75
[Reconstruction of hepatic artery in adult to adult living donor liver transplantation in 104 patients]. Zhonghua Yi Xue Za Zhi (2009) 0.75